Cerebellar ataxias

Purpose of reviewThe term ‘cerebellar ataxias’ encompasses the various cerebellar disorders encountered during daily practice. Patients exhibit a cerebellar syndrome and can also present with pigmentary retinopathy, extrapyramidal movement disorders, pyramidal signs, cortical symptoms (seizures, cognitive impairment/behavioural symptoms), and peripheral neuropathy. The clinical diagnosis of subtypes of ataxias is complicated by the salient overlap of the phenotypes between genetic subtypes. The identification of the causative mutations of many hereditary ataxias and the development of relevant animal models bring hope for effective therapies in neurodegenerative ataxias. Recent findingsWe describe the current classification of cerebellar ataxias and underline the recent discoveries in molecular pathogenesis. Cerebellar disorders can be divided into sporadic forms and inherited diseases. Inherited ataxias include autosomal recessive cerebellar ataxias, autosomal dominant cerebellar ataxias/spinocerebellar ataxia) and episodic ataxias, and X-linked ataxias. From a motor control point of view, the leading theories of ataxia are based on neural representations or ‘internal models’ to emulate fundamental natural processes such as body motion. SummaryRecent molecular advances have direct implications for research and daily practice. We provide a framework for the diagnosis of ataxias. For the first time, the therapeutic agents under investigation are targeted to deleterious pathways.

[1]  F. Gabreëls,et al.  Clinical and molecular genetic characteristics of patients with cerebrotendinous xanthomatosis. , 2000, Brain : a journal of neurology.

[2]  M. Zeviani The expanding spectrum of nuclear gene mutations in mitochondrial disorders. , 2001, Seminars in cell & developmental biology.

[3]  S. Perlman Ataxias , 2002, Journal of the Neurological Sciences.

[4]  T. Ebner,et al.  Hereditary cerebellar ataxia progressively impairs force adaptation during goal-directed arm movements. , 2004, Journal of neurophysiology.

[5]  Y. Agid,et al.  Frequency and phenotypic spectrum of ataxia with oculomotor apraxia 2: a clinical and genetic study in 18 patients. , 2004, Brain : a journal of neurology.

[6]  H. Waterham,et al.  Molecular basis of Refsum disease: Sequence variations in Phytanoyl‐CoA Hydroxylase (PHYH) and the PTS2 receptor (PEX7) , 2004, Human mutation.

[7]  L. Peltonen,et al.  Infantile onset spinocerebellar ataxia is caused by recessive mutations in mitochondrial proteins Twinkle and Twinky. , 2005, Human molecular genetics.

[8]  I. Harting,et al.  Mutations in SIL1 cause Marinesco-Sjögren syndrome, a cerebellar ataxia with cataract and myopathy , 2005, Nature Genetics.

[9]  J. Lupski,et al.  Defective DNA single-strand break repair in spinocerebellar ataxia with axonal neuropathy-1 , 2005, Nature.

[10]  K. Vlahovicek,et al.  Molecular analysis of the HEXA gene in Italian patients with infantile and late Onset Tay‐Sachs disease: detection of fourteen novel alleles , 2005, Human mutation.

[11]  Y. Liou,et al.  Brain-specific BNIP-2-homology protein Caytaxin relocalises glutaminase to neurite terminals and reduces glutamate levels , 2006, Journal of Cell Science.

[12]  L. Kaczmarek,et al.  Functional analysis of a novel potassium channel (KCNA1) mutation in hereditary myokymia , 2006, Neurogenetics.

[13]  M. Zeviani,et al.  The spectrum of clinical disease caused by the A467T and W748S POLG mutations: a study of 26 cases. , 2006, Brain : a journal of neurology.

[14]  T. Ebner,et al.  Force field effects on cerebellar Purkinje cell discharge with implications for internal models , 2006, Nature Neuroscience.

[15]  Masao Ito Cerebellar circuitry as a neuronal machine , 2006, Progress in Neurobiology.

[16]  K. Caldecott,et al.  TDP1-dependent DNA single-strand break repair and neurodegeneration. , 2006, Mutagenesis.

[17]  S. Perlman,et al.  Histone deacetylase inhibitors reverse gene silencing in Friedreich's ataxia , 2006, Nature chemical biology.

[18]  C. Espinós,et al.  Orphanet Journal of Rare Diseases BioMed Central Review , 2006 .

[19]  U Walter,et al.  Morphological basis for the spectrum of clinical deficits in spinocerebellar ataxia 17 (SCA17). , 2006, Brain : a journal of neurology.

[20]  N. Ramnani The primate cortico-cerebellar system: anatomy and function , 2006, Nature Reviews Neuroscience.

[21]  M. Mori,et al.  Intravenous immunoglobulin therapy for Miller Fisher syndrome , 2007, Neurology.

[22]  S. Rivera,et al.  Volumetric brain changes in females with fragile X-associated tremor/ataxia syndrome (FXTAS) , 2007, Neurology.

[23]  S. Nelson,et al.  A new episodic ataxia syndrome with linkage to chromosome 19q13. , 2007, Archives of neurology.

[24]  A. Munnich,et al.  Prenyldiphosphate synthase, subunit 1 (PDSS1) and OH-benzoate polyprenyltransferase (COQ2) mutations in ubiquinone deficiency and oxidative phosphorylation disorders. , 2007, The Journal of clinical investigation.

[25]  J. Brunberg,et al.  Fragile X‐associated tremor/ataxia syndrome: Clinical features, genetics, and testing guidelines , 2007, Movement disorders : official journal of the Movement Disorder Society.

[26]  J. V. van Swieten,et al.  Diagnosis and management of early‐ and late‐onset cerebellar ataxia , 2006, Clinical genetics.

[27]  D. Marmolino,et al.  Friedreich’s Ataxia: From the (GAA)n Repeat Mediated Silencing to New Promising Molecules for Therapy , 2009, The Cerebellum.

[28]  J. Jen Hereditary Episodic Ataxias , 2008, Annals of the New York Academy of Sciences.

[29]  E. Tournier-Lasserve,et al.  Large CACNA 1 A Deletion in a Family With Episodic Ataxia Type 2 , 2008 .

[30]  Osamu Onodera,et al.  Sporadic ataxias in Japan – a population-based epidemiological study , 2008, The Cerebellum.

[31]  V. Cheung,et al.  ATM gene mutations result in both recessive and dominant expression phenotypes of genes and microRNAs. , 2008, American journal of human genetics.

[32]  J. Cruysberg,et al.  ARSACS in the Dutch population: a frequent cause of early-onset cerebellar ataxia , 2008, neurogenetics.

[33]  Caterina Tonon,et al.  Idebenone in Friedreich's ataxia. , 2008, Expert opinion on pharmacotherapy.

[34]  Andreas R. Luft,et al.  Magnetic resonance imaging in spinocerebellar ataxias , 2008, The Cerebellum.

[35]  A. Bastian,et al.  Cerebellum and the deciphering of motor coding , 2007, The Cerebellum.

[36]  K. Devriendt,et al.  A novel genomic disorder: a deletion of the SACS gene leading to Spastic Ataxia of Charlevoix–Saguenay , 2008, European Journal of Human Genetics.

[37]  L. Tranebjaerg,et al.  Novel SIL1 mutations and exclusion of functional candidate genes in Marinesco–Sjögren syndrome , 2008, European Journal of Human Genetics.

[38]  D. Rubinsztein,et al.  Spinocerebellar ataxias caused by polyglutamine expansions: A review of therapeutic strategies , 2008, The Cerebellum.

[39]  A. Monticelli,et al.  Recombinant Human Erythropoietin Increases Frataxin Protein Expression Without Increasing mRNA Expression , 2008, The Cerebellum.